Overview

Travoprost Five Day Posology Study

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the safety and efficacy of three concentrations of travoprost ophthalmic solution (Groups A, B and C) administered eight times daily.

Phase:

Phase 2

Details

Lead Sponsor:

Alcon Research

Treatments:

Travoprost